Novel inflammatory targets for immunotherapies in pediatric patients with trichotillomania

dc.contributor.authorKutuk, MO
dc.contributor.authorTufan, AE
dc.contributor.authorKilicaslan, F
dc.contributor.authorMutluer, T
dc.contributor.authorGokcen, C
dc.contributor.authorKaradag, M
dc.contributor.authorYektas, C
dc.contributor.authorKandemir, H
dc.contributor.authorBuber, A
dc.contributor.authorAksu, GG
dc.contributor.authorTopal, Z
dc.contributor.authorGiray, A
dc.contributor.authorCelik, F
dc.contributor.authorAcikbas, U
dc.contributor.authorKutuk, O
dc.date.accessioned2024-07-18T12:07:44Z
dc.date.available2024-07-18T12:07:44Z
dc.description.abstractImmune dysregulation may be important in the etiology of obsessive-compulsive and related disordersandbody-focusedrepetitivebehaviors, such as Trichotillomania (TTM). The role of inflammation and inflammatory markers in TTM has received relatively little attention. This study was aimed to determine the expression levels of inflammatory markers (i.e. IL-1 beta, IL-1 alpha, IL-4, IL-6, IL-17, TNF-alpha and TGF-5) in peripheral blood mononuclear cells of children with TTM and healthy controls and to evaluate their association with clinical variables. Seventy-seven patients with TTM and 107 healthy controls were enrolled in the study. Peripheral blood was collected in standardized conditions. The mean age of patients and controls did not differ significantly (10.8 +/- 4.4 and 12.0 +/- 3.2 years; respectively). The majority of patients with TTM and controls were females (n = 55, 71.4 % and n = 55, 51.4 %; respectively); with a greater preponderance of females among TTM. Patients with TTM had significantly elevated expression levels of TNF-alpha, IL-6 and IL-17 compared to controls. However, the expression level of IL-4 was significantly reduced in TTM patients compared to controls. Accordingly, we found a proinflammatory state in TTM and those findings may suggest novel treatment options for TTM and further, crossdisciplinary studies focusing on neuro- inflammation in TTM conducted on larger samples are needed.
dc.identifier.issn0171-2985
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10608
dc.language.isoEnglish
dc.publisherELSEVIER GMBH
dc.subjectN-ACETYLCYSTEINE
dc.subjectDOUBLE-BLIND
dc.subjectSECUKINUMAB
dc.subjectDISORDERS
dc.subjectRECEPTORS
dc.subjectCHILDREN
dc.subjectDISEASE
dc.subjectFAMILY
dc.subjectCELLS
dc.subjectBETA
dc.titleNovel inflammatory targets for immunotherapies in pediatric patients with trichotillomania
dc.typeArticle

Files